Report Detail
Global Active Pharma Ingredient Market Insights and Forecast to 2026
- RnM4153357 |
- 24 August, 2020 |
- Global |
- 183 Pages |
- QYResearch |
- Pharma & Healthcare
Active Pharma Ingredient market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharma Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Active Pharma Ingredient market is segmented into
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Segment by Application, the Active Pharma Ingredient market is segmented into
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Other Therapeutic Applications
Regional and Country-level Analysis
The Active Pharma Ingredient market is analysed and market size information is provided by regions (countries).
The key regions covered in the Active Pharma Ingredient market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Active Pharma Ingredient Market Share Analysis
Active Pharma Ingredient market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Active Pharma Ingredient business, the date to enter into the Active Pharma Ingredient market, Active Pharma Ingredient product introduction, recent developments, etc.
The major vendors covered:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
1 Study Coverage
- 1.1 Active Pharma Ingredient Product Introduction
- 1.2 Market Segments
- 1.3 Key Active Pharma Ingredient Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Active Pharma Ingredient Market Size Growth Rate by Type
- 1.4.2 Innovative Active Pharmaceutical Ingredients
- 1.4.3 Generic Active Pharmaceutical Ingredients
- 1.5 Market by Application
- 1.5.1 Global Active Pharma Ingredient Market Size Growth Rate by Application
- 1.5.2 Oncology
- 1.5.3 Cardiovascular Disease
- 1.5.4 Diabetes
- 1.5.5 Central Nervous System and Neurological Disorders
- 1.5.6 Endocrinology
- 1.5.7 Other Therapeutic Applications
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Active Pharma Ingredient Market Size, Estimates and Forecasts
- 2.1.1 Global Active Pharma Ingredient Revenue 2015-2026
- 2.1.2 Global Active Pharma Ingredient Sales 2015-2026
- 2.2 Global Active Pharma Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Active Pharma Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Active Pharma Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Active Pharma Ingredient Competitor Landscape by Players
- 3.1 Active Pharma Ingredient Sales by Manufacturers
- 3.1.1 Active Pharma Ingredient Sales by Manufacturers (2015-2020)
- 3.1.2 Active Pharma Ingredient Sales Market Share by Manufacturers (2015-2020)
- 3.2 Active Pharma Ingredient Revenue by Manufacturers
- 3.2.1 Active Pharma Ingredient Revenue by Manufacturers (2015-2020)
- 3.2.2 Active Pharma Ingredient Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Active Pharma Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Active Pharma Ingredient Revenue in 2019
- 3.2.5 Global Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Active Pharma Ingredient Price by Manufacturers
- 3.4 Active Pharma Ingredient Manufacturing Base Distribution, Product Types
- 3.4.1 Active Pharma Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Active Pharma Ingredient Product Type
- 3.4.3 Date of International Manufacturers Enter into Active Pharma Ingredient Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Active Pharma Ingredient Market Size by Type (2015-2020)
- 4.1.1 Global Active Pharma Ingredient Sales by Type (2015-2020)
- 4.1.2 Global Active Pharma Ingredient Revenue by Type (2015-2020)
- 4.1.3 Active Pharma Ingredient Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Active Pharma Ingredient Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Active Pharma Ingredient Sales Forecast by Type (2021-2026)
- 4.2.2 Global Active Pharma Ingredient Revenue Forecast by Type (2021-2026)
- 4.2.3 Active Pharma Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Active Pharma Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Active Pharma Ingredient Market Size by Application (2015-2020)
- 5.1.1 Global Active Pharma Ingredient Sales by Application (2015-2020)
- 5.1.2 Global Active Pharma Ingredient Revenue by Application (2015-2020)
- 5.1.3 Active Pharma Ingredient Price by Application (2015-2020)
- 5.2 Active Pharma Ingredient Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Active Pharma Ingredient Sales Forecast by Application (2021-2026)
- 5.2.2 Global Active Pharma Ingredient Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Active Pharma Ingredient Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Active Pharma Ingredient by Country
- 6.1.1 North America Active Pharma Ingredient Sales by Country
- 6.1.2 North America Active Pharma Ingredient Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Active Pharma Ingredient Market Facts & Figures by Type
- 6.3 North America Active Pharma Ingredient Market Facts & Figures by Application
7 Europe
- 7.1 Europe Active Pharma Ingredient by Country
- 7.1.1 Europe Active Pharma Ingredient Sales by Country
- 7.1.2 Europe Active Pharma Ingredient Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Active Pharma Ingredient Market Facts & Figures by Type
- 7.3 Europe Active Pharma Ingredient Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Active Pharma Ingredient by Region
- 8.1.1 Asia Pacific Active Pharma Ingredient Sales by Region
- 8.1.2 Asia Pacific Active Pharma Ingredient Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Active Pharma Ingredient Market Facts & Figures by Type
- 8.3 Asia Pacific Active Pharma Ingredient Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Active Pharma Ingredient by Country
- 9.1.1 Latin America Active Pharma Ingredient Sales by Country
- 9.1.2 Latin America Active Pharma Ingredient Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Active Pharma Ingredient Market Facts & Figures by Type
- 9.3 Central & South America Active Pharma Ingredient Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Active Pharma Ingredient by Country
- 10.1.1 Middle East and Africa Active Pharma Ingredient Sales by Country
- 10.1.2 Middle East and Africa Active Pharma Ingredient Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Active Pharma Ingredient Market Facts & Figures by Type
- 10.3 Middle East and Africa Active Pharma Ingredient Market Facts & Figures by Application
11 Company Profiles
- 11.1 Teva
- 11.1.1 Teva Corporation Information
- 11.1.2 Teva Description and Business Overview
- 11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Teva Active Pharma Ingredient Products Offered
- 11.1.5 Teva Related Developments
- 11.2 Novartis
- 11.2.1 Novartis Corporation Information
- 11.2.2 Novartis Description and Business Overview
- 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Novartis Active Pharma Ingredient Products Offered
- 11.2.5 Novartis Related Developments
- 11.3 Pfizer
- 11.3.1 Pfizer Corporation Information
- 11.3.2 Pfizer Description and Business Overview
- 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Pfizer Active Pharma Ingredient Products Offered
- 11.3.5 Pfizer Related Developments
- 11.4 Johnson & Johnson
- 11.4.1 Johnson & Johnson Corporation Information
- 11.4.2 Johnson & Johnson Description and Business Overview
- 11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Johnson & Johnson Active Pharma Ingredient Products Offered
- 11.4.5 Johnson & Johnson Related Developments
- 11.5 Mylan
- 11.5.1 Mylan Corporation Information
- 11.5.2 Mylan Description and Business Overview
- 11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Mylan Active Pharma Ingredient Products Offered
- 11.5.5 Mylan Related Developments
- 11.6 North China Pharmaceutical Group
- 11.6.1 North China Pharmaceutical Group Corporation Information
- 11.6.2 North China Pharmaceutical Group Description and Business Overview
- 11.6.3 North China Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 North China Pharmaceutical Group Active Pharma Ingredient Products Offered
- 11.6.5 North China Pharmaceutical Group Related Developments
- 11.7 Dr. Reddy’s Laboratories
- 11.7.1 Dr. Reddy’s Laboratories Corporation Information
- 11.7.2 Dr. Reddy’s Laboratories Description and Business Overview
- 11.7.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Products Offered
- 11.7.5 Dr. Reddy’s Laboratories Related Developments
- 11.8 Roche
- 11.8.1 Roche Corporation Information
- 11.8.2 Roche Description and Business Overview
- 11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Roche Active Pharma Ingredient Products Offered
- 11.8.5 Roche Related Developments
- 11.9 Aurobindo pharma
- 11.9.1 Aurobindo pharma Corporation Information
- 11.9.2 Aurobindo pharma Description and Business Overview
- 11.9.3 Aurobindo pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Aurobindo pharma Active Pharma Ingredient Products Offered
- 11.9.5 Aurobindo pharma Related Developments
- 11.10 Sun Pharmaceutical Industries
- 11.10.1 Sun Pharmaceutical Industries Corporation Information
- 11.10.2 Sun Pharmaceutical Industries Description and Business Overview
- 11.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Products Offered
- 11.10.5 Sun Pharmaceutical Industries Related Developments
- 11.1 Teva
- 11.1.1 Teva Corporation Information
- 11.1.2 Teva Description and Business Overview
- 11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Teva Active Pharma Ingredient Products Offered
- 11.1.5 Teva Related Developments
- 11.12 Bayer
- 11.12.1 Bayer Corporation Information
- 11.12.2 Bayer Description and Business Overview
- 11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Bayer Products Offered
- 11.12.5 Bayer Related Developments
- 11.13 BASF
- 11.13.1 BASF Corporation Information
- 11.13.2 BASF Description and Business Overview
- 11.13.3 BASF Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 BASF Products Offered
- 11.13.5 BASF Related Developments
- 11.14 DSM
- 11.14.1 DSM Corporation Information
- 11.14.2 DSM Description and Business Overview
- 11.14.3 DSM Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 DSM Products Offered
- 11.14.5 DSM Related Developments
- 11.15 Zhejiang Medicine
- 11.15.1 Zhejiang Medicine Corporation Information
- 11.15.2 Zhejiang Medicine Description and Business Overview
- 11.15.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Zhejiang Medicine Products Offered
- 11.15.5 Zhejiang Medicine Related Developments
- 11.16 Biocon
- 11.16.1 Biocon Corporation Information
- 11.16.2 Biocon Description and Business Overview
- 11.16.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Biocon Products Offered
- 11.16.5 Biocon Related Developments
- 11.17 Johnson Matthey
- 11.17.1 Johnson Matthey Corporation Information
- 11.17.2 Johnson Matthey Description and Business Overview
- 11.17.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Johnson Matthey Products Offered
- 11.17.5 Johnson Matthey Related Developments
- 11.18 Hisun Pharmacy
- 11.18.1 Hisun Pharmacy Corporation Information
- 11.18.2 Hisun Pharmacy Description and Business Overview
- 11.18.3 Hisun Pharmacy Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Hisun Pharmacy Products Offered
- 11.18.5 Hisun Pharmacy Related Developments
- 11.19 Cambrex
- 11.19.1 Cambrex Corporation Information
- 11.19.2 Cambrex Description and Business Overview
- 11.19.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Cambrex Products Offered
- 11.19.5 Cambrex Related Developments
- 11.20 Shandong Xinhua Pharmaceutical
- 11.20.1 Shandong Xinhua Pharmaceutical Corporation Information
- 11.20.2 Shandong Xinhua Pharmaceutical Description and Business Overview
- 11.20.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Shandong Xinhua Pharmaceutical Products Offered
- 11.20.5 Shandong Xinhua Pharmaceutical Related Developments
- 11.21 Lonza group
- 11.21.1 Lonza group Corporation Information
- 11.21.2 Lonza group Description and Business Overview
- 11.21.3 Lonza group Sales, Revenue and Gross Margin (2015-2020)
- 11.21.4 Lonza group Products Offered
- 11.21.5 Lonza group Related Developments
- 11.22 Huahai Pharmaceutical
- 11.22.1 Huahai Pharmaceutical Corporation Information
- 11.22.2 Huahai Pharmaceutical Description and Business Overview
- 11.22.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.22.4 Huahai Pharmaceutical Products Offered
- 11.22.5 Huahai Pharmaceutical Related Developments
- 11.23 Haerbin Pharmaceutical Group
- 11.23.1 Haerbin Pharmaceutical Group Corporation Information
- 11.23.2 Haerbin Pharmaceutical Group Description and Business Overview
- 11.23.3 Haerbin Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
- 11.23.4 Haerbin Pharmaceutical Group Products Offered
- 11.23.5 Haerbin Pharmaceutical Group Related Developments
- 11.24 Cipla
- 11.24.1 Cipla Corporation Information
- 11.24.2 Cipla Description and Business Overview
- 11.24.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
- 11.24.4 Cipla Products Offered
- 11.24.5 Cipla Related Developments
- 11.25 Tian Yao
- 11.25.1 Tian Yao Corporation Information
- 11.25.2 Tian Yao Description and Business Overview
- 11.25.3 Tian Yao Sales, Revenue and Gross Margin (2015-2020)
- 11.25.4 Tian Yao Products Offered
- 11.25.5 Tian Yao Related Developments
- 11.26 Lupin
- 11.26.1 Lupin Corporation Information
- 11.26.2 Lupin Description and Business Overview
- 11.26.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
- 11.26.4 Lupin Products Offered
- 11.26.5 Lupin Related Developments
- 11.27 North East Pharmaceutical
- 11.27.1 North East Pharmaceutical Corporation Information
- 11.27.2 North East Pharmaceutical Description and Business Overview
- 11.27.3 North East Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.27.4 North East Pharmaceutical Products Offered
- 11.27.5 North East Pharmaceutical Related Developments
- 11.28 Albemarle
- 11.28.1 Albemarle Corporation Information
- 11.28.2 Albemarle Description and Business Overview
- 11.28.3 Albemarle Sales, Revenue and Gross Margin (2015-2020)
- 11.28.4 Albemarle Products Offered
- 11.28.5 Albemarle Related Developments
- 11.29 Shandong Lukang Pharmaceutical
- 11.29.1 Shandong Lukang Pharmaceutical Corporation Information
- 11.29.2 Shandong Lukang Pharmaceutical Description and Business Overview
- 11.29.3 Shandong Lukang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.29.4 Shandong Lukang Pharmaceutical Products Offered
- 11.29.5 Shandong Lukang Pharmaceutical Related Developments
- 11.30 Jiangsu Hengrui Medicine
- 11.30.1 Jiangsu Hengrui Medicine Corporation Information
- 11.30.2 Jiangsu Hengrui Medicine Description and Business Overview
- 11.30.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
- 11.30.4 Jiangsu Hengrui Medicine Products Offered
- 11.30.5 Jiangsu Hengrui Medicine Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Active Pharma Ingredient Market Estimates and Projections by Region
- 12.1.1 Global Active Pharma Ingredient Sales Forecast by Regions 2021-2026
- 12.1.2 Global Active Pharma Ingredient Revenue Forecast by Regions 2021-2026
- 12.2 North America Active Pharma Ingredient Market Size Forecast (2021-2026)
- 12.2.1 North America: Active Pharma Ingredient Sales Forecast (2021-2026)
- 12.2.2 North America: Active Pharma Ingredient Revenue Forecast (2021-2026)
- 12.2.3 North America: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
- 12.3 Europe Active Pharma Ingredient Market Size Forecast (2021-2026)
- 12.3.1 Europe: Active Pharma Ingredient Sales Forecast (2021-2026)
- 12.3.2 Europe: Active Pharma Ingredient Revenue Forecast (2021-2026)
- 12.3.3 Europe: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Active Pharma Ingredient Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Active Pharma Ingredient Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Active Pharma Ingredient Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Active Pharma Ingredient Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Active Pharma Ingredient Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Active Pharma Ingredient Sales Forecast (2021-2026)
- 12.5.2 Latin America: Active Pharma Ingredient Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Active Pharma Ingredient Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Active Pharma Ingredient Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Active Pharma Ingredient Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Active Pharma Ingredient Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Active Pharma Ingredient Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Active Pharma Ingredient Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Active Pharma Ingredient. Industry analysis & Market Report on Active Pharma Ingredient is a syndicated market report, published as Global Active Pharma Ingredient Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Active Pharma Ingredient market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
